Search Results - "Ligibel, J"

Tai Chi and Qigong for cancer-related symptoms and quality of life: a systematic review and meta-analysis by Wayne, Peter M., Lee, M.S., Novakowski, J., Osypiuk, K., Ligibel, J., Carlson, L.E., Song, R.

“…Purpose This study aims to summarize and critically evaluate the effects of Tai Chi and Qigong (TCQ) mind–body exercises on symptoms and quality of life (QOL)…”
Get full text

Comprehensive Lifestyle Improvement Program for Prostate Cancer (CLIPP) is associated with improvement in weight and components of metabolic syndrome in men exposed to androgen deprivation therapy for prostate cancer by Algotar, A. M., Hsu, C. H., Chow, H-H., Dougherty, S. T., Babiker, H. M., Marrero, D. G., Abraham, I., Kumar, R., Ligibel, J. A., Courneya, K. S., Smith, T. E., Jones, P. A., Lopez, J. N., Niemiro, G., Ramakumar, S., Hoy, R. D., Mack, C., Thomson, C. A.

“…Background Androgen deprivation therapy (ADT) for prostate cancer is associated with adverse effects, such as obesity and metabolic syndrome, which increase…”
Get full text

Weight loss, physical and psychological patient reported outcomes (PROs) among obese patients (pts) with early breast cancer (BC) by Di Meglio, A., El-Mouhebb, M., Michiels, S., Jones, L., Martin, E., Matias, M., Lohmann Palhares, A.E., Joly, F., Vanlemmens, L., Everhard, S., Martin, A.L., Lemonnier, J., Arveux, P., Cottu, P.H., Coutant, C., Del Mastro, L., Partridge, A.H., André, F., Ligibel, J.A., Vaz-Luis, I.

Get full text

Overweight, obesity and weight gain after breast cancer (BC): A prospective clinical study by Di Meglio, A., El-Mouhebb, M., Michiels, S., Jones, L., Annonay, M., Zingarello, A., Matias, M., Everhard, S., Martin, A.L., Arveux, P., Tredan, O., Soulie, P., Cottu, P.H., Partridge, A.H., Del Mastro, L., Ligibel, J.A., André, F., Vaz-Luis, I.

Get full text

Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy by Chavarri-Guerra, Y, Higgins, M J, Szymonifka, J, Cigler, T, Liedke, P, Partridge, A, Ligibel, J, Come, S E, Finkelstein, D, Ryan, P D, Goss, P E

“…Background: Acquiring resistance to endocrine therapy is common in metastatic hormone-receptor-positive breast cancer (MBC). These patients most often…”
Get full text

Protocol for a feasibility and early efficacy study of the Comprehensive Lifestyle Improvement Program for Prostate Cancer-2 (CLIPP2) by Algotar, A.M., Kumar, R., Babiker, H.M., Dougherty, S.T., Hsu, C.H., Chow, H.-H., Smith, T.E., Marrero, D.G., Courneya, K.S., Abraham, I., Ligibel, J.A., Thomson, C.A.

“…Although androgen deprivation therapy (ADT) for prostate cancer demonstrates improved overall and disease-free survival, it is associated with adverse effects…”
Get full text

413 Relationship Between Body Mass Index (BMI) and Outcomes in Node-positive Breast Cancer Patients Receiving Chemotherapy–Results From CALGB/Intergroup 9741 by Ligibel, J, Cirrincione, C, Citron, M, Ingle, J, Gradishar, W, Martino, S, Hudis, C, Winer, E, Berry, D

Get full text

Preserving and Interpreting a Shared Mission: Peter Dougherty, Chief Ahgosa, and Northern Michigan's Old Mission by Mary Ann Heidemann, Ted J. Ligibel

Get full text

Trastuzumab/chemotherapy combinations in metastatic breast cancer by Ligibel, Jennifer A, Winer, Eric P

“…The past decade has seen many advances in the treatment of advanced breast cancer, including the development of both new chemotherapy drugs and novel targeted…”
Get more information

2031O Randomized trial of a telephone-based weight loss intervention in overweight and obese patients (pts) with breast cancer (BC): The MEDEA trial by Luis, I.V. Vaz, Di Meglio, A., Martin, E., Vanlemmens, L., Segura-Djezzar, C., Bouleuc, C., Tredan, O., Pistilli, B., Crane, T., Soldato, D., Charles, C., Barbier, A., Raynard, B., Mangin, A., Coquet, B., Jacob, G., Bonastre, J., Michiels, S., Chaltiel, D., Ligibel, J.

Get full text

358TiP Phase Ib/II study of antibody-drug conjugate, sacituzumab govitecan, in combination with the PARP inhibitor, talazoparib, in metastatic triple-negative breast cancer by Bardia, A., Spring, L.M., Juric, D., Partridge, A., Ligibel, J., Kuter, I., Peppercorn, J., Parsons, H., Ryan, P., Chawla, D., Attaya, V., Fitzgerald, D.M., Viscosi, E., Lormill, B., Shellock, M., Moy, B., Tolaney, S.M., Ellisen, L.W.

Get full text

Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32 by Goodwin, Pamela J, Parulekar, Wendy R, Gelmon, Karen A, Shepherd, Lois E, Ligibel, Jennifer A, Hershman, Dawn L, Rastogi, Priya, Mayer, Ingrid A, Hobday, Timothy J, Lemieux, Julie, Thompson, Alastair M, Pritchard, Kathleen I, Whelan, Timothy J, Mukherjee, Som D, Chalchal, Haji I, Oja, Conrad D, Tonkin, Katia S, Bernstein, Vanessa, Chen, Bingshu E, Stambolic, Vuk

“…Metformin may improve metabolic factors (insulin, glucose, leptin, highly sensitive C-reactive protein [hs-CRP]) associated with poor breast cancer outcomes…”
Get full text

Risk Perceptions and Psychosocial Outcomes of Women With Ductal Carcinoma In Situ: Longitudinal Results From a Cohort Study by Partridge, Ann, Adloff, Kristie, Blood, Emily, Dees, E. Claire, Kaelin, Carolyn, Golshan, Mehra, Ligibel, Jennifer, de Moor, Janet S., Weeks, Jane, Emmons, Karen, Winer, Eric

“…Background Ductal carcinoma in situ (DCIS) has a generally favorable overall prognosis, with a systemic recurrence rate of approximately 1%, a local recurrence…”
Get full text

1739PWeight loss, physical and psychological patient reported outcomes (PROs) among obese patients (pts) with early breast cancer (BC) by Di Meglio, A, El-Mouhebb, M, Michiels, S, Jones, L, Martin, E, Matias, M, Lohmann Palhares, A E, Joly, F, Vanlemmens, L, Everhard, S, Martin, A L, Lemonnier, J, Arveux, P, Cottu, P H, Coutant, C, Del Mastro, L, Partridge, A H, André, F, Ligibel, J A, Vaz-Luis, I

Get full text

1738POverweight, obesity and weight gain after breast cancer (BC): A prospective clinical study by Di Meglio, A, El-Mouhebb, M, Michiels, S, Jones, L, Annonay, M, Zingarello, A, Matias, M, Everhard, S, Martin, A L, Arveux, P, Tredan, O, Soulie, P, Cottu, P H, Partridge, A H, Del Mastro, L, Ligibel, J A, André, F, Vaz-Luis, I

Get full text

Psychosocial and sexual functioning of survivors of breast cancer by Kornblith, Alice B, Ligibel, Jennifer

“…The literature documents that the majority of breast cancer survivors have adjusted well after their first 2 years since diagnosis. However, there is a subset…”
Get full text

Abstract P1-10-18: Contraception use in young women with breast cancer by Rosenberg, SM, Dutton, CR, Ligibel, J, Barry, W, Ruddy, KJ, Sprunck-Harrild, K, Emmons, KM, Partridge, AH

“…Abstract Background: Young women with breast cancer need highly effective contraception given the potential implications of unplanned pregnancy for optimal…”
Get full text

Preserving and Interpreting a Shared Mission: Peter Dougherty, Chief Ahgosa, and Northern Michigan's Old Mission by Heidemann, Mary, Ligibel, Ted

Get full text

Abstract S3-03: Randomized trial of exercise vs. usual care on aromatase inhibitor-associated arthralgias in women with breast cancer: The hormones and physical exercise (HOPE) study by Irwin, ML, Cartmel, B, Gross, C, Ercolano, E, Fiellin, M, Capozza, S, Rothbard, M, Zhou, Y, Harrigan, M, Sanft, T, Schmitz, K, Neogi, T, Hershman, D, Ligibel, J

“…Abstract PURPOSE: Arthralgias occur in up to 50% of women with breast cancer treated with adjuvant aromatase inhibitors (AIs), and are one of the most common…”
Get full text

Abstract OT2-4-02: Young and strong: A randomized trial to evaluate a program for young women with breast cancer by Partridge, AH, Ruddy, KJ, Barry, WT, Greaney, M, Sprunck-Harrild, K, Meyer, ME, Baker, EL, Ligibel, J, Emmons, KM

“…Abstract Young women with newly diagnosed breast cancer face substantial challenges including higher risk of disease recurrence and likelihood of harboring a…”
Get full text